IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 89 filers reported holding IMMUNOVANT INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,325,512 | +16.1% | 1,102,514 | -42.6% | 2.01% | +44.0% |
| Q2 2023 | $36,444,253 | +78.4% | 1,921,152 | +45.9% | 1.40% | +57.9% |
| Q1 2023 | $20,427,151 | +5.8% | 1,317,031 | +21.0% | 0.89% | +12.2% |
| Q4 2022 | $19,314,325 | +353.8% | 1,088,131 | +799.7% | 0.79% | +912.8% |
| Q3 2020 | $4,256,000 | -70.9% | 120,940 | -79.8% | 0.08% | -71.1% |
| Q2 2020 | $14,610,000 | – | 600,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 1,500,000 | $26,625 | 8.85% |
| Deep Track Capital, LP | 9,710,000 | $172,352,500 | 7.24% |
| Logos Global Management LP | 3,150,000 | $55,912,500 | 6.55% |
| Ikarian Capital, LLC | 966,700 | $17,158,925 | 4.14% |
| COMMODORE CAPITAL LP | 1,150,505 | $20,421 | 3.08% |
| TCG Crossover Management, LLC | 854,853 | $15,173,641 | 2.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 519,614 | $9,223,149 | 2.64% |
| COWEN AND COMPANY, LLC | 1,250,000 | $22,187,500 | 2.32% |
| BVF INC/IL | 2,561,000 | $45,457,750 | 1.92% |
| Eventide Asset Management | 3,693,720 | $65,563,530 | 1.29% |